BioSpace News Archive

Business

Precision Optics Corporation Schedules First Quarter Conference Call

Management has scheduled a conference call for 5:00 p.m. ET on Tuesday, November 14th to review the Company’s financial results and future outlook.

November 9, 2017
·
1 min read
Drug Development

Prima BioMed: New Eftilagimod Alpha (LAG-3Ig or IMP321) Data for Presentation at the Society for Immunotherapy of Cancer (SITC) 2017 Annual Meeting

The data will be presented in the poster titled “Pushing the accelerator and releasing the brake: testing the soluble LAG-3 protein (IMP321).

November 9, 2017
·
3 min read
Business

Medical Device Innovation Consortium Announces CEO William V. Murray is Stepping Down to Return to Private Sector; Board Begins Search for New Leader

The Medical Device Innovation Consortium (MDIC) CEO William V. (Bill) Murray today announced he will step down as President & CEO effective February 2, 2018 to return to the private sector.

November 9, 2017
·
2 min read
Business

REGENXBIO Reports Third Quarter 2017 Financial Results and Recent Operational Highlights

Cash, cash equivalents and marketable securities were $191.1 million as of September 30, 2017, compared to $159.0 million as of December 31, 2016.

November 9, 2017
·
12 min read
Business

iCAD Reports Third Quarter 2017 Financial Results

Total revenue of $7.0 million, up 17% year-over-year.

November 9, 2017
·
25 min read
Business

Cascadian Therapeutics Reports Third Quarter 2017 Financial Results

Cash, cash equivalents and investments totaled $113.0 million as of September 30, 2017, compared to $62.8 million at December 31, 2016.

November 9, 2017
·
9 min read
Business

Rockwell Medical Reports Third Quarter Results

Sales were $14.6 million, an increase of 14.1% or $1.8 million over third quarter of 2016.

November 9, 2017
·
9 min read
Business

CymaBay Reports Third Quarter 2017 Financial Results and Corporate Updates

Conference call today at 4:30pm EST.

November 9, 2017
·
9 min read
Business

Cidara Provides Corporate Update and Reports Third Quarter 2017 Financial Results

Conference call and webcast today at 1:05 p.m. PST/4:05 p.m. EST

November 9, 2017
·
10 min read
Business

miRagen Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Revenue was $1.6 million for the third quarter of 2017, compared to $0.9 million for the third quarter of the prior year.

November 9, 2017
·
14 min read